Features of 80S mammalian ribosome and its subunits by Budkevich, Tatyana V. et al.
4736–4744 Nucleic Acids Research, 2008, Vol. 36, No. 14 Published online 16 July 2008
doi:10.1093/nar/gkn424
Features of 80S mammalian ribosome
and its subunits
Tatyana V. Budkevich
1,2, Anna V. El’skaya
2 and Knud H. Nierhaus
1,*
1Max-Planck-Institut fu ¨r Molekulare Genetik, Ihnestr. 73, D-14195 Berlin, Germany and
2Institute of Molecular
Biology and Genetics, National Academy of Sciences of Ukraine, 150, Zabolotnogo str., Kiev, 03143, Ukraine
Received May 9, 2008; Revised June 18, 2008; Accepted June 19, 2008
ABSTRACT
It is generally believed that basic features of riboso-
mal functions are universally valid, but a systematic
test still stands out for higher eukaryotic 80S ribo-
somes. Here we report: (i) differences in tRNA and
mRNA binding capabilities of eukaryotic and bacte-
rial ribosomes and their subunits. Eukaryotic 40S
subunits bind mRNA exclusively in the presence of
cognate tRNA, whereas bacterial 30S do bind mRNA
already in the absence of tRNA. 80S ribosomes bind
mRNA efficiently in the absence of tRNA. In con-
trast, bacterial 70S interact with mRNA more
productively in the presence rather than in the
absence of tRNA. (ii) States of initiation (Pi), pre-
translocation (PRE) and post-translocation (POST)
of the ribosome were checked and no significant
functional differences to the prokaryotic counter-
part were observed including the reciprocal linkage
between A and E sites. (iii) Eukaryotic ribosomes
bind tetracycline with an affinity 15 times lower
than that of bacterial ribosomes (Kd 30kM and
1–2kM, respectively). The drug does not effect enzy-
matic A-site occupation of 80S ribosomes in con-
trast to non-enzymatic tRNA binding to the A-site.
Both observations explain the relative resistance of
eukaryotic ribosomes to this antibiotic.
INTRODUCTION
Translational decoding and peptide-bond formation are
reactions of the ribosomal elongation cycle, the most con-
served phase of ribosomal functions. On the contrary, the
initiation, termination and recycling phases show signiﬁ-
cant diﬀerences between bacterial ribosomes on one
hand and archaeal and eukaryotic ribosomes on the
other indicated by speciﬁc factors (1–3). Factors of the
elongation phase such as EF-Tu and EF-G in bacteria
and EF1 and EF2 in archaea and eukaryotes have
a common ancestor, respectively, and demonstrate the
same mode of actions, namely delivery of aminoacyl-
tRNA to the ribosomal A-site (EF-Tu and EF1) and pro-
motion of translocation (EF-G and EF2). Only under
deﬁned growth conditions such as low pH and high salts
bacteria require a third elongation factor LepA (EF4) that
is also present in all bacteria related organelles, namely
mitochondria and chloroplasts (4; Z. Karim, M. Pech,
Y. Qin and K.H. Nierhaus, unpublished data).
A characteristic feature of ribosomes from all three
domains is the presence of three tRNA-binding sites,
namely the A, P and E sites (5). Moreover, it was shown
for bacteria (6) and yeast (7) that A and E ribosomal sites
are connected via reciprocal linkage that is occupation of
the E-site induces a low aﬃnity for binding an A-tRNA,
and vice versa, the E-tRNA release is triggered by A-site
occupation, precisely after decoding and before accommo-
dation (8). This allostery between A and E-sites is an
intrinsic feature of ribosomes, and lower eukaryotes
such as yeast even need a unique elongation factor 3
(eEF3) to execute the allosteric interaction. eEF3 is an
essential ATPase and it is required after translocation
for opening the E site to allow E-tRNA release upon
A-site occupation (7,9).
Regardless of the above-mentioned similarities between
prokaryotic and eukaryotic elongation cycles ﬁrst results
of cryo-EM analysis indicate that the dynamical behavior
of eukaryotic and prokaryotic ribosomes is diﬀerent (10).
Another conspicuous diﬀerence concerns the mRNA
tunnel upstream the E site. In 80S ribosomes the
mRNA of this region is surrounded by proteins that are
not present in prokaryotes, whereas in 70S ribosomes both
ribosomal proteins and rRNA are found (11,12).
Undoubtedly, discovery and design of new antibacterial
drugs need information about organization, functions and
evolutionary conservation of mammalian elongation
apparatus. Here we compare some basic functional fea-
tures of ribosomes from higher eukaryotes (rabbit liver)
with those from bacteria concerning binding of mRNA
and tRNA and the eﬀects of tetracycline, member of
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MATERIALS AND METHODS
Materials
Re-associated 80S ribosomes from rabbit liver free of
endogenous tRNAs and mRNAs were prepared according
to (13) with slight modiﬁcations: in order to wash endo-
genous RNases from polysomes the post-mitochondrial
supernatant was centrifuged through a 1M sucrose cush-
ion, which contained 0.5MKCl. Re-association was con-
ﬁrmed by analytical centrifugation for 18000r.p.m., 17h
(Beckman SW40 rotor). The ribosome concentrations
were calculated assuming the following ratios: 60pmol/
A260 for 40S subunits, 30pmol/A260 for 60S subunits
and 20pmol/A260 for 80S ribosomes.
Heteropolymeric MFVK-mRNA 50-GGGAAAAGAA
AAGAAAAGAAA-AUG-UUC-GUU-AAA-GAAAAG
AAAAGAAAU-30 is 49 nucleotides long with four codons
Met-Phe-Val-Lys in the middle was prepared with run-oﬀ
transcription, according to (14). Note that the MFVK-
mRNA does not contain a classical Shine-Dalgarno
(SD) sequence unless the 50-GGG triplet which can func-
tion as a weak SD in the absence of tRNA.
tRNA
Phe and tRNA
Val were puriﬁed from tRNAbulk
derived from bovine liver by HPLC chromatography
using ion-exchange DEAE and reversed phase Hypersil 5
C4 columns. The plasmids for human tRNA
Lys
3 and yeast
tRNA
Met
i were kindly provided by Dr M. Mirande (Gif-
sur-Yvette, France) and Dr E. Sattlegger (Auckland,
New Zealand), respectively. N-acetyl-[
3H]Phe-tRNA
Phe
(Ac[
3H]Phe-tRNA
Phe), [
14C]Val-tRNA
Val and [
14C]Lys-
tRNA
Lys
3 were puriﬁed by reversed-phase HPLC on a
Nucleosil 300-5 C4 column using a methanol gradient as
described (15). 30-end
32P-labeling of tRNA was performed
according to (16). 50-end
32P-labeling of MFVK-mRNA
was done according to (17).
The elongation factors eEF1A and eEF2 from rabbit
liver were isolated using combination of gel-ﬁltration
and ion-exchange chromatography as described (18,19).
All complexes were prepared in polyamine buﬀer A,
which contained 20mM HEPES-KOH (pH 7.5 at 08C),
5mMMgCl2, 100mM KCl, 0.6mM spermine, 0.8mM
spermidine and 6mM 2-mercaptoethanol (20).
mRNA bindingto ribosome and ribosomal subunits
Pre-incubation of 40S, 60S and 80S ribosomes with
32P-labeled heteropolymeric MFVK-mRNA (100d.p.m./
pmol) during 2min at 378C (molar ratio mRNA:40S/
60S/80S=10:1) was followed by an incubation for
15min at 378C in the presence or absence of deacylated
tRNA (molar ratio tRNA:40S/60S/80S=2:1). Then
40pmol of each sample were loaded on 10–30% sucrose
gradient (Beckman SW40 rotor) in buﬀer A and were
centrifuged for 18000r.p.m., 17h.
This technique was chosen instead of nitrocellulose ﬁl-
tration to decrease background level. A pre-treatment of
ﬁlters with 0.5M KOH (258C, 25min) (21) proposed as
solution for this trouble for short oligonucleotides did not
work in our case for heteropolymeric mRNA (49nt).
The experiments with bacterial 70S and 30S were
done in parallel in ionic conditions adjusted for an optimal
bacterial translational system [20mM HEPES-KOH
(pH 7.5at 08C), 4.5mMMgCl2, 6mM 2-mercaptoethanol,
150mMKCl, 0.05mM spermine and 2mM
spermidine] (8,22).
Construction ofthe Pi complex
Re-associated 80S ribosomes (0.4mM) were incubated with
MFVK-mRNA for 2min at 378C. Then Ac[
3H]Phe-
tRNA
Phe (2400d.p.m./pmol) in indicated amounts was
added and incubation continued for 20min at 378C. The
nitrocelluloseﬁltration (tRNAbinding)andthepuromycin
reaction were performed as described elsewhere (23).
Construction ofthe PREcomplex
80S ribosomes programmed with MFVK-mRNA and
occupied by Ac[
3H]Phe-tRNA
Phe (described above) were
incubated for 15min at 378C with pre-formed ternary
complex (3min 378C; buﬀer A with 0.4mM GTP,
2mM phosphoenolpyruvate, 0.2mg/ml pyruvate kinase;
molar ratio ternary complex:80S=2:1) containing
eEF1A GTP [
14C]Val-tRNA
Val (580 dpm/pmol) for enzy-
matic A-site binding. The puromycin reaction yielded no
product indicating that tRNA
Phe was at the P site and
di-peptide Phe-Val-tRNA at the A site. In experiments
with non-hydrolysable analog of GTP, ternary complexes
were formed and bound to 80S ribosomes in the presence
of 0.4mM GDPNP.
Monitoring di-peptideformation by HPLC
Aliquots of PRE complex containing 2pmol of 80S were
withdrawn and the binding and puromycin reactivity were
assessed as described above. Another 8–10pmol were ana-
lyzed for di-peptide synthesis by HPLC chromatography
according to (24). The amount of formed di-peptide was
normalized to the active fraction of ribosomes determined
by the amount of bound Ac[
3H]Phe-tRNA
Phe.
Construction ofthe POST complexand subsequent
ternarycomplex binding
Pi complexes programmed with MFVK-mRNA and
Ac[
3H]Val-tRNA
Val (2500d.p.m./pmol) at the P site were
incubatedwith[
32P]tRNA
Phe(3000d.p.m./pmol)tooccupy
the E site. The puromycin reaction indicated that about
70% of AcVal-tRNA remained at the P site. In such a
manner a POST complex could be constructed without
elongation factor 2 (eEF2) avoiding a puriﬁcation (ultra-
centrifugation) step, which can be harmful for ribosomes.
Increasing amounts of ternary complexes containing
[
14C]Lys-tRNA
Lys
3 (680dpm/pmol; AAA codon at the
A site) were added. The fate of each tRNA could be moni-
tored due to three diﬀerent isotopic labels used. This set of
experiments was carried out in the presence of 3mM ATP.
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Stock solution (15mM) of tetracycline (USB Corp., USA)
contained 25% ethanol and 10mM Tris, the pH was
adjusted to 7.8 and the solution was used immediately
(25). Controls (minus tetracycline) were performed with
assay mixtures containing corresponding concentrations
of ethanol and Tris. In all cases parallel assays with 70S
ribosomes were used as control and reference.
Poly(U)-directed poly(Phe) synthesis by E. coli ribo-
somes was performed as described in (22) in the pre-
sence of appropriate amounts of tetracycline (0.1 10
–6
to 300 10
–6M) in a polyamine buﬀer containing
4.5mM Mg
2+, 3mM ATP, 1.5mM GTP, 5mM acetyl-
phosphate, 40mg poly(U), 5pmol 70S ribosomes, 140mM
[
14C]Phe ( 60dpm/pmol), 15 A260/ml tRNAbulk and S100
fraction. The amount of hot TCA precipitable radioactive
material was determined after 60min incubation at 378C.
For the mammalian translation system optimal condi-
tions were used according to ref. (26), namely 20mM
Hepes–KOH (pH 7.5 at 08C), 2.5mM Mg(acetate)2,
150mM K(acetate), 3.5mM spermidine, 4mM b-mercap-
toethanol, 9% glycerol, 21mM phosphocreatine, 0.9mM
ATP, 0.1mM GTP. The system was homogeneous: ribo-
somes and S-100 proteins were from rabbit liver and
tRNAbulk from bovine liver. Overall procedure was the
same as that used for E. coli translation system.
To test a possible inﬂuence of the drug on the P-site
occupation MFVK-mRNA programmed ribosomes were
incubated with increased amount of tetracycline (50 10
–6
to 500 10
–6M) 10min at 378C and then Ac[
14C]Phe-
tRNA (1147d.p.m./pmol) was added as described above.
A-site binding was tested as follows: ribosomes carrying
deacylated tRNA at the P site were incubated with the
drug (50 10
–6 to 500 10
–6M), thereafter a two-molar
excess of AcPhe-tRNA or ternary complex was added as
substrate for the A site.
Aﬃnity of tetracycline binding to free ribosomes was
studiedusing[
3H]tetracycline(NEN,Inc.,500d.p.m./pmol).
RESULTS
mRNAand tRNA binding
Binding of [
32P]mRNA to pro- and eukaryotic ribosomes
and their small subunits in the absence and presence of
tRNA was compared by ultracentrifugation in 10–30%
sucrose gradients (Figure 1). 40S subunits bind mRNA
only in the presence of cognate tRNA
Phe (Figure 1a and
b, left panels). Replacing tRNA
Phe by non-cognate
tRNA
Ala abolished binding to background level
(Figure 1b, dashed line). In contrast, 30S can interact
with mRNA even in the absence of tRNA (Figure 1a
and b, right panels). In the absence of template tRNA
does not bind to 40S (Table 1) or 30S subunits (27,28).
It follows that simultaneous presence of both mRNA and
cognate tRNA ([
32P] tRNA
Met
i or [
32P]tRNA
Phe)i sa n
absolute requirement for their binding to small eukaryotic
ribosomal subunits allowing stoichiometric binding of
both ligands. Note that we are analyzing non-enzymatic
binding of deacylated tRNA to small subunits, whereas it
is well documented that in vivo scanning 40S subunits do
bind Met-tRNA
Met
i in presence of initiation factors (see
‘Discussion’ section).
The large eukaryotic 60S subunit do not bind mRNA at
all (proﬁles not shown), but can interact with deacylated
tRNA even in the absence of mRNA ( 0.6 tRNA/60S,
Table 1), in agreement with the observation that only one
tRNA-binding site, the E site, is available on isolated
bacterial 50S subunits (27).
mRNA comigrates with 80S ribosomes in the absence
and presence of tRNA (Figure 1c and d, left panels)
indicating a tRNA-independent mRNA binding to mam-
malian ribosomes. An analogous result was observed in
ﬁlter-binding assays (0.77 tRNA/80S without mRNA,
Table 1).
70S ribosomes bind one MFVK-mRNA per ribosome
in the presence of tRNA
Phe, without tRNA only half the
value was observed (Figure 1c and d, right panels).
Characterization of Pi state
Programmed ribosomes containing only one tRNA at the
P site represent the Pi state (i for initiation) (25). We have
used AcPhe-tRNA, an analog of peptidyl-tRNA, for spe-
ciﬁc P site ﬁlling.
A saturation curve for AcPhe-tRNA leveled oﬀ at 0.8
tRNA per 80S in the presence of MFVK-mRNA contain-
ing only one codon for tRNA
Phe, i.e. 80% of the ribo-
somes of our preparation participate in tRNA binding
in the presence of template. In the absence of template
up to 0.5 AcPhe-tRNA could be bound per 80S
(Figure 2a and b, respectively).
The bound AcPhe-tRNA reacted quantitatively with
puromycin in the presence of template indicating P-site
location. Interestingly, in the absence of a template for-
mation of AcPhe-puromycin exceeded by far the amount
of bound AcPhe-tRNA and stopped only when the total
input amount was consumed. For example, in Figure 2b
two AcPhe-puromycin formed per ribosome versus 0.5
AcPhe-tRNA bound per ribosome. It follows that one
ribosome can perform more than one puromycin reaction
(in Figure 2b—four reactions) until the AcPhe-tRNA
input has been used, but only in the absence of message
(repetitive puromycin reaction, see ‘Discussion’ section).
This observation has important consequences for a reli-
able interpretation of a puromycin reaction.
Characterization of PRE state
ThePREstate(pretranslocationalstate)ischaracterizedby
a tRNA occupation of both A and P sites. After occupying
the P-site with Ac[
3H]Phe-tRNA
Phe the A site was ﬁlled
with a pre-formed ternary complex containing [
14C]Val-
tRNA
Val corresponding to the GUU codon at the A site.
Figure 3a shows that with increasing A-site occupation the
puromycin reaction of the P-site bound Ac[
3H]Phe-tRNA
steadily decreased indicating formation of the di-peptide
AcPhe-Val-tRNA at the A site. The formed di-peptide
was directly demonstrated in a parallel experiment via
HPLC analysis. The peak containing both radioactive
amino acids (Ac[
3H]Phe and [
14C]Val) in stoichiometric
amounts (Figure 3b, fractions 32–35) indicates di-peptides.
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14C]Val-tRNA
Val and Ac[
3H]Phe-tRNA
Phe, respectively.
When the ternary complex was bound to the A site in
the presence of the non-cleavable GTP analogue GDPNP,
75% of the AcPhe-tRNA still reacted with puromycin,
whereas almost none of the Val-tRNA participated in
reaction (Figure 3c). Thus, the ternary complex is ﬁxed
on the ribosome after the decoding process at the A site,
but does not hamper the puromycin reaction with AcPhe-
tRNA at the P site. It follows that Val-tRNA did not
yet accommodate, i.e. the ternary complex is present in
the A/T state as it is observed with bacterial ribosomes (8).
Allosteric interplay between A andE sites
The E-tRNA is released upon A-site occupation,
indicating that the A site can inﬂuence the E site via a
negative cooperativity. Also occupation of the E site inﬂu-
ences negatively the tRNA aﬃnity of the A site; the A site
ﬂips into a low-aﬃnity state upon E site occupation as
shown with ribosomes from bacteria and lower eukaryotes
(6,7), preventing premature accommodation and peptide-
bond formation of the aminoacyl-tRNA during or before
decoding at the A/T state (29). This allosteric phenome-
non of a reciprocal linkage between A and E sites is instru-
mental for an accurate protein synthesis (5).
To test whether this feature is also valid in higher euka-
ryotic 80S ribosomes, a posttranslocational complex was
constructed with Ac[
3H]Val-tRNA
Val at the P site
(MFVK-mRNA, GUU codon) and
32P-labeled deacylated
tRNA
Phe at the E site (UUC codon). According to the
allosteric three-site model (6), the A-site occupation via
addition of [
14C]Lys-tRNA
Lys
3 (AAA codon) together
Figure 1. Sucrose gradient proﬁles of small ribosomal subunits and ribosomes (A260) in the presence of [
32P]mRNA (dotted lines) and—where
indicated—tRNA
Phe (dashed line in 1b represents experiment in the presence of non-cognate tRNA
Ala). Panels on the left and right sides show
proﬁles obtained with eukaryotic and bacterial ribosomes, respectively.
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responding release of deacylated tRNA from the E site.
Note that eEF2 was not present in the reaction mixture
and therefore a translocation cannot occur (see ‘Materials
and Methods’ section). Three diﬀerent radioactive labels
(
3H,
14C and
32P) present in one assay allow a simulta-
neous analysis of the tRNA fates at the three tRNA bind-
ing sites (Figure 4). Since about 65% of the ribosomes
contained Ac[
3H]Val-tRNA
Val at the P-site, a maximum
of 65% of ribosomes can have an occupied E site and thus
can be present in the POST state. Addition of increasing
amounts of A-site substrate (ternary complex containing
[
14C]Lys-tRNA
Lys
3 ) triggers the release of E-tRNA from
62% of the 80S ribosomes. The fact that the binding of
Lys-tRNA saturates at about 90% obviously indicates
that about 30% of this tRNA goes to ribosomes with
an empty P site.
Figure 2. AcPhe-tRNA binding (red lines) and puromycin reaction
(black lines) with 80S ribosomes in the presence (a) and absence (b)
of MFVK-mRNA.  , tRNA bound per ribosome in a binding assay or
acylated tRNA per ribosome reacting with puromycin.
Figure 3. Addition of a ternary complexes (green) to a Pi state of 80S
ribosomes. (a) Binding of the ternary complex eEF1A GTP Val-tRNA
to 80S ribosomes in the Pi state carrying an AcPhe-tRNA (red line) at
the P site in the presence of MFVK-mRNA. (b) Di-peptide formation
in the assay shown in (a). (c) eEF1A GDPNP Val-tRNA (green bars) is
added to Pi states carrying AcPhe-tRNA (red bars).  , tRNA bound
per ribosome in a binding assay or acylated tRNA per ribosome react-
ing with puromycin.
Table 1. Binding of deacylated [
32P]tRNA
Phe to eukaryotic ribosomes
and subunits
80S 40S
a 60S
 mRNA +mRNA  mRNA +mRNA  mRNA +mRNA
0.77 0.07 1 0.01 0.1 0.01 1 0.03 0.56 0.03 0.59 0.06
ain experiments with 40S subunits bovine deacylated [
32P]tRNA
Phe
or yeast [
32P]tRNAMet
i were used yielding the same results.
The numbers give the bound tRNA per ribosome ( ), when two-molar
excess was added over ribosomes. If indicated, MFVK-mRNA was
used; at least three experiments were performed.
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Tetracycline (Tet) binds to the 16S rRNA of 30S subunits
in a sequence unspeciﬁc manner and blocks the binding of
aminoacyl-tRNA to the A site (30–33). Titration of empty
70S and 80S with labelled [
3H]Tet revealed an at least 15
times smaller apparent Kd with bacterial than with euka-
ryotic ribosomes (1–2mM and  30mM, respectively;
Figure 5a). Binding was not yet saturated in the case of
80S ribosomes probably due to lower-aﬃnity binding
site(s), since more than one binding site per 70S ribosome
has been described before (32–34).
The drug slightly inhibits poly(Phe) synthesis of 80S
(10% reduction of ribosomal activity in the presence of
300mM), whereas inhibition was observed even below
5mM in the bacterial system (70S, Figure 5b). Next,
tRNA binding to P- and A-sites was studied in the pre-
sence of Tet. AcPhe-tRNA binding to the P site was not
aﬀected even by 500mM in both systems (data not shown),
whereas the A site binding of AcPhe-tRNA was sensitive
to Tet in the bacterial and—interestingly—in the eukaryo-
tic system as well (Figure 5c, blue lines). It follows that the
speciﬁcity of the drug action seen in prevention of non-
enzymatic tRNA binding to the A site was similar in both
systems. However, when enzymatic A-site occupation with
ternary complexes was studied, signiﬁcant blockage of
ternary complex binding was only observed in the bacte-
rial rather than in the eukaryotic system (Figure 5c,
dashed and solid red lines, respectively).
DISCUSSION
We analyzed basic functions of bacterial and eukaryotic
ribosomes and their subunits and used the MFVK-mRNA
with a length of 49nt and a coding region in the middle for
Met-Phe-Val-Lys lacking all translation initiation regula-
tory elements inherent to eukaryotic or prokaryotic
mRNAs. Therefore it is a proper model-mRNA to com-
pare mRNA and tRNA binding to ribosomes. The most
conspicuous diﬀerence is the observation that the 40S sub-
units cannot bind either deacylated tRNA or mRNA
alone, whereas 30S do bind eﬃciently mRNA in the
absence of tRNA. mRNA binds only to 40S ribosomal
subunits in the presence of cognate deacylated tRNA
Phe
rather then non-cognate tRNA
Ala (Figure 1a and b, left
panels) indicating that tRNA ﬁxes the reading frame via
codon-anticodon interaction and stabilizes 40S–mRNA
interactions. On the other hand, a 40S subunit binds
the ternary complex eIF2 GTP Met-tRNAMet
i in the
absence of mRNA during initiation (43S initiation com-
plex) (2) before it interacts with the cap-region of mRNA
in the presence of other initiation factors (48S initiation
complex). Therefore, deacylated or acylated tRNA will
not interfere with the initiation process, be it the
scanning mechanism (35) or the tethering and clustering
mechanisms (36).
The speciﬁc 30S feature, namely interaction with
mRNA in the absence of tRNA, reﬂects the initiation
mode of Gram-negative bacteria, where ribosomal protein
S1 in the absence of a Shine-Dalgarno (SD) sequence is
a key recognition element in mRNA binding (37,38). It is
shown that S1 is required for translation of most, if not
all, natural mRNAs in E. coli, where only 57.1% of genes
contain SD sequence (37,38). Together our data of ultra-
centrifugation and previously published results indicate
that mRNA binding precedes that of tRNA on 30S
(38,39). When both mRNA and cognate tRNA are pres-
ent, the small ribosomal subunits bind both molecules
eﬃciently and stoichiometrically, i.e. the binding of
tRNA and mRNA to small subunits is highly cooperative.
80S ribosomes bind tRNA to the P site in the absence of
mRNA (Table 1). This fact is long known for 70S ribo-
somes (40,41). Concerning mRNA binding in the absence
of tRNA, 80S bind template in the absence of tRNA more
eﬃcient than 70S ribosomes (Figure 1c; only 50% of 70S
bound mRNA under the same conditions). Presence of
both tRNA and mRNA stabilizes the resulting ribosome
complex as indicated by stoichiometric binding values
with 70S and 80S ribosomes. Recently, the stabilization
eﬀect was directly measured with 70S ribosomes applying
optical tweezers (42).
When the P sites of 80S ribosomes were titrated with
AcPhe-tRNA in the presence of MFVK-mRNA, the bind-
ing curve leveled oﬀ at about 0.8 molecules per 80S as did
the puromycin reaction (Figure 2a), whereas in the
absence of mRNA the binding did not exceed 0.5 mole-
cules per 80S (Figure 2b). Interestingly, the puromycin
reaction surpassed the binding value by far in the absence
of mRNA and went on until the input of AcPhe-tRNA
was depleted. What happens is obviously a repetitive reac-
tion, namely after the formation of AcPhe-puromycin the
remaining deacylated tRNA
Phe at the P site is chased by
AcPhe-tRNA, so that the same ribosome can perform
more then one puromycin reaction as long as the input
AcPhe-tRNA is consumed. Under polyamine-conditions
codon-anticodon interaction is able to ﬁx deacylated
tRNA at the P site thus preventing chasing, whereas
non-programmed 80S ribosomes bind tRNA only
weakly allowing chasing. A repetitive puromycin reaction
is therefore an indication for the absence of mRNA or
non-saturating mRNA conditions. The weak binding in
the absence of mRNA can be explained by analogy with
70S ribosomes: a P-tRNA in non-programmed 70S
Figure 4. Binding of the ternary complex eEF1A GTP [
14C]Lys-tRNA
(green) to 80S ribosomes in the POST state carrying an Ac[
3H]Val-
tRNA (red) at the P and a [
32P]tRNA
Phe (orange) at the E site. The
100% binding corresponds to 0.4 tRNA
Phe bound per ribosome ( ).
For details see text.
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and interacts exclusively with the large subunit (43). The
important conclusion is that the puromycin reaction is
only reliable in the presence of saturating amount of
mRNA, otherwise it will be going on with time.
According to cryo-EM studies in bacteria the A-site
occupation occurs in two structural clearly distinct steps,
the decoding process and the accommodation (44). During
decoding the aminoacyl-residue is >50A ˚ apart from
the peptidyltransferase center (A/T state) giving room
for free access of puromycin to the peptidyltransferase
center. This state is visualized in the presence of the
non-cleavable GTP analog GDPNP. Only after a success-
ful decoding the aminoacyl-tRNA ﬂips fully into the
A site (accommodation). Therefore, the fact that in the
presence of GDPNP AcPhe-tRNA interacts signiﬁcantly
with puromycin whereas the adjacent Val-tRNA
does not (Figure 3c) indicates that also higher eukaryotic
ribosomes run through the A/T state during A-site occu-
pation, which is in accord with an analysis by cryo-
electronmicroscopy (T. V. Budkevich, J. Giesebrecht,
K. H. Nierhaus and C. T. M. Spahn, manuscript in
preparation).
We have presented evidence that the reciprocal linkage
between the A and E sites is of outmost importance for
accurate protein synthesis (5), i.e. E-site occupation
induces a low aﬃnity mode for tRNA binding to the
A site and vice versa, occupation of the A site triggers
the release of the E-tRNA. This is also true for higher
eukaryotic ribosomes, since occupation of the A site
of POST ribosomes is accompanied by a corresponding
release of the E-tRNA (Figure 4), the intervening
P-tRNA is not aﬀected serving for a welcome internal
control. We conclude that the allosteric interaction of A
and E sites is universal, since it has also been demon-
strated in a bacterial system (6,45) as well as with yeast
80S ribosomes (7).
Tetracycline binds to the A site and prevents tRNA
binding to this site (32,33,46,47). The primary binding
site of this drug is nested in a universal rRNA fold of
the sugar-phosphate backbone and not depending on
a conserved sequence. Therefore, in principal, it should
bind to all kinds of ribosomes, the 70S as well as the
80S type, with comparable aﬃnity. Most contacts
are formed with the irregular shallow/minor groove
of h34 (1196–1200, 1053–1056; E. coli numbering), and
Figure 5. Analysis of tetracycline binding to 70S and 80S ribosomes. (a) Binding of [
3H]Tet to empty 70S (diamonds, dashed line) and 80S (circles,
solid line) ribosomes. (b) Poly(U)-poly(Phe) synthesis in bacterial (diamonds, dashed line) and mammalian (circles, solid line) systems in the presence
of increasing amounts of tetracycline. The 100% corresponds to 60 and 15 incorporated Phe per ribosome in the bacterial and eukaryotic system,
respectively. (c) Eﬀect of tetracycline on non-enzymatic A-site binding with AcPhe-tRNA (blue) and enzymatic A-site binding with ternary complex
(red). Deacylated tRNAfMet and tRNAMet
i were used to occupy the P site in 70S (dashed line) and 80S systems (solid line), respectively. The 100%
corresponds to a   value of 0.7 for both 70S and 80S ribosomes for non-enzymatic A-site binding and 0.83 and 0.6 for 70S and 80S ribosomes,
respectively, for enzymatic A-site binding. (d) Parts of helices 34 from phylogenetic conservation maps superimposed onto the bacterial (E. coli),
archaeal (Methanococcus jannaschii) and eukaryotic (Saccharomyces cerevisiae) 16S-type secondary structures (http://www.rna.ccbb.utexas.edu/).
ACGU, 98+% conserved positions; acgu, 90–98% conserved positions; ﬁlled circle, 80–90% conserved positions; open circle, less than 80%
conserved positions. The nucleotides of the right strand are connected for the sake of clarity; number of sequences considered: Bacteria, 4214;
Archaea, 174; Eukaryota, 1939.
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ﬁrst time, we compare drug binding to 70S and 80S ribo-
somes, and surprisingly, we observe binding of the anti-
biotic to empty 80S ribosomes with a 15-fold reduced
aﬃnity as compared with that to 70S ribosomes
(Figure 5a). We speculate that this phenomenon might
be due to structural diﬀerences of the primary tetracycline
binding site between bacterial and eukaryotic rRNAs at
helix h34 around residue 1200 (Figure 5d). Comparison
of secondary structures of the 16S-type rRNA from the
three phylogenetic domains (6326 sequences, http://
www.rna.ccbb.utexas.edu/) revealed that in almost all
eukaryotic sequences helix 34 contains one extra nucleo-
tide before the universal A1204, which can cause a diﬀe-
rent tertiary organization of phosphate backbone in this
area and is possibly responsible for the increase of
the apparent Kd value. The observation of partial resis-
tance of mammalian ribosomes to Tet was also conﬁrmed
in poly(U)-poly(Phe) synthesis (Figure 5b). Our data
are in line with old results (48), where Tet at 400mM con-
centration was more inhibitory (90%) in [
14C]Leu incor-
poration into E. coli total protein than in a rat liver system
(28%).
Tet blocks non-enzymatic A-site occupation with acety-
lated tRNA
Phe (but not non-enzymatic P-site occupation;
data not shown) in both systems to a comparable extent
(Figure 5c, blue lines), which indicates that antibiotic
binds to corresponding sites in 70S and 80S ribosomes.
In striking contrast, interaction of eukaryotic ternary
complex with 80S ribosomes was practically unaﬀected
at up to 500mM of the drug, whereas binding of bacterial
analog was blocked for about 30% (Figure 5c, red lines).
A possible reason is that in spite of the lower aﬃnity
of Tet for eukaryotic ribosomes mentioned above the aﬃ-
nity of tRNA to the A site in the absence of elongation
factors (EF-Tu/eEF1A) is low enough to be blocked
by Tet in both the bacterial and eukaryotic systems.
Indeed, non-enzymatic binding to the A site of bacterial
ribosomes occurs with an aﬃnity which is about two
orders of magnitudes smaller than that of enzymatic bind-
ing (49). Obviously, the relative resistance of eukaryotic
systems to the eﬀect of Tet—the prerequisite for its appli-
cation in medicine—is caused by two factors: (i) the lower
intrinsic aﬃnity as shown by binding experiments
with empty ribosomes (Figure 5a) and (ii) the stronger
drug-chasing capability of eukaryotic ternary complexes
(Figure 5c).
In vivo eukaryotic cells are essentially resistant against
Tet in contrast to bacterial cells. It is generally believed
that this is due to the fact that the drug can easier pene-
trate the bacterial rather than the eukaryotic cell mem-
brane (50). Our results reveal additional and possibly
decisive explanation of a preferential inhibition of bacter-
ial rather than eukaryotic ribosomes.
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